Xiaflex (collagenase clostridium histolyticum) / SOBI, Asahi Kasei, Endo  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

14 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo
NCT00954746 / 2008-007872-99: Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859

Completed
N/A
645
US, Europe, RoW
Endo Pharmaceuticals
Dupuytren's Disease
05/13
05/13
UBIEX-DC, NCT04607187: Ultrasound B Mode Imaging and Elastography

Completed
N/A
20
US
Theresa Bass-Goldman, Endo Pharmaceuticals
Dupuytren's Contractures
11/14
12/14
NCT01876498: Registry of Patient With M. Dupuytren and Validation of the Brief MHQ

Completed
N/A
60
Europe
Xiaflex surgery
Schulthess Klinik
Dupuytren Contracture, Collagen Shrinkage, CRF
07/15
07/15
NCT01444729: Post Approval Commitment Study

Completed
N/A
305
Europe
Xiapex, surgery
Endo Pharmaceuticals
Dupuytren's Contracture
11/15
11/15
NCT01446432: Validation of Two New Questionnaires for Dupuytren's Disease

Unknown status
N/A
80
US
Robert Hotchkiss, Auxilium Pharmaceuticals, Inc.
Dupuytren's Disease
12/15
12/15
NCT01538017: Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture

Completed
N/A
50
Europe
Xiapex, XIAPEX® - Pfizer UK, Percutaneous needle fasciotomy
Jeppe Lange, MD
Dupuytrens Contracture
10/16
10/16
NCT03331926: Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease

Completed
N/A
199
NA
Xiapex
Jeppe Lange
Dupuytren Contracture
05/17
12/19
NCT02301078: Short-term Function and Pain After Treatment for Dupuytren's Disease

Unknown status
N/A
60
Canada
Percutaneous Needle Aponeurotomy, needle aponeurotomy, fasciotomy, Collagenase clostridium histolyticum, Xiaflex
Sunnybrook Health Sciences Centre
Dupuytren Disease
10/17
11/17
NCT02298829 / 2014-004239-37: Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease

Completed
N/A
184
US
Subjects Previously Treated with AA4500
Endo Pharmaceuticals
Peyronie's Disease
04/18
04/18
NCT03774264: Treatment Response to Xiaflex for Men With Peyronie's Disease

Completed
N/A
80
US
University of Miami, Endo Pharmaceuticals
Peyronie Disease
07/21
07/21
NCT04680156: Long-term Follow-up Durability (Efficacy) Study of EN3835 for the Treatment of AC of the Shoulder (Frozen Shoulder)

Terminated
N/A
120
US
Previously treated with EN3835 up to 1.74 mg or Placebo in EN3835-210 or the pivotal phase 3 studies
Endo Pharmaceuticals
Adhesive Capsulitis, Frozen Shoulder
09/22
09/22
NCT05249257: Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity

Completed
N/A
20
US
Endo Pharmaceuticals
Cellulite, Laxity; Skin, Edematous Fibrosclerotic Panniculopathy
09/22
09/22
Penile LiSWT, NCT05646602: Focused Shock Wave Therapy Outcomes in Peyronie's Disease and Erectile Dysfunction

Withdrawn
N/A
800
US
Collagenase Clostridium Histolyticum, Xiaflex, Duolith SD1 T-TOP
Mayo Clinic
Peyronie Disease, Penile Curvature, Erectile Dysfunction
12/24
12/24
NCT06065436: Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease

Recruiting
N/A
60
US
Collagenase Clostridium Histolyticum, Xiaflex, Storz Duolith LiSWT
Mayo Clinic
Peyronie Disease, Erectile Dysfunction
12/25
12/25

Download Options